Tuesday, 02 January 2024 12:17 GMT

Synthetic Biology Market Analysis 2026-2031: Genome Engineering Accounts For 33.21% Share, With Asia-Pacific As The Fastest-Growing Region, Says Mordor Intelligence


(MENAFN- PR Newswire)

HYDERABAD, India, April 9, 2026 /PRNewswire/ -- According to Mordor Intelligence, the synthetic biology market size USD 19.75 billion in 2025 and is projected to grow to USD 23.53 billion in 2026, reaching an estimated USD 56.48 billion by 2031, registering a CAGR of 19.14% over the forecast period (2026–2031), driven by rapid advancements in genetic engineering, increasing demand for bio-based products, and expanding applications across healthcare, agriculture, and industrial biotechnology. The market is gaining momentum as organizations worldwide leverage synthetic biology to design and engineer biological systems for improved efficiency, sustainability, and innovation.

The synthetic biology market is being shaped by the growing use of engineered organisms in drug development, vaccine production, and gene therapies. The ability to manipulate DNA and create customized biological pathways is enabling breakthroughs in precision medicine and biopharmaceutical manufacturing. Increasing investments in research and development, along with strong collaboration between academic institutions and biotechnology companies, are further supporting market expansion. Industrial applications are also contributing significantly to market growth, with synthetic biology being used to produce biofuels, specialty chemicals, and sustainable materials. The shift toward environmentally friendly production methods is encouraging industries to adopt bio-based alternatives, reducing dependence on traditional chemical processes. Additionally, advancements in DNA sequencing, gene synthesis, and automation technologies are improving scalability and reducing production costs.

Synthetic Biology Market Share by Region

Asia-Pacific is emerging as a high-growth region due to expanding biotechnology capabilities, rising government support, and increasing adoption of synthetic biology across healthcare, agriculture, and industrial sectors.

North America represents a significant share of the synthetic biology market, driven by strong research funding, advanced biotechnology infrastructure, and the presence of leading industry players. The region continues to lead in innovation and commercialization of synthetic biology solutions.

Europe holds a notable market position, supported by increasing focus on sustainable development, government initiatives promoting bioeconomy strategies, and growing investment in biotechnology research.

Synthetic Biology Market Trends & Forecast

Growing Applications in Healthcare and Biopharmaceuticals

Synthetic biology is increasingly being used in the development of advanced therapeutics, vaccines, and gene-based treatments, supporting innovation in healthcare.

Rising Demand for Sustainable Bio-based Products

Industries are adopting synthetic biology to produce environmentally friendly alternatives, driving growth in biofuels, bioplastics, and specialty chemicals.

Soumya Goud, Senior Research Manager, Mordor Intelligence, says, "The synthetic biology market is advancing as organizations explore new approaches to production, healthcare, and sustainable materials. Mordor Intelligence applies a structured review of diverse data sources, offering a more balanced and comparable perspective than analyses with limited validation or narrower market coverage."

Synthetic Biology Market Segmentation Overview

By Product

    Core Products
      DNA/RNA Synthesizers Gene Editing Kits & Enzymes
    Enabling Products
      Oligonucleotides Cloning Vectors
    Enabled Products
      Cell-Free Systems Engineered Micro-organisms

By Technology

    Genome Engineering DNA/RNA Synthesis Bioinformatics & CAD Tools Bioprocessing & Automation

By Application

    Healthcare
      Drug Discovery Gene & Cell Therapy
    Chemicals & Biofuels
      Specialty Chemicals Advanced Biofuels
    Food & Agriculture
      Alternative Proteins Crop Trait Engineering
    Other (Bio-security, Environment, Data Storage)

By End-User

    Industrial Biotech Companies Pharma & Biopharma Academic & Research Institutes Defense & Government Labs

By Geography

    North America
      United States Canada Mexico
    Europe
      Germany United Kingdom France Italy Spain Rest of Europe
    Asia-Pacific
      China Japan India South Korea Australia Rest of Asia-Pacific
    Middle East
      GCC South Africa Rest of Middle East
    South America
      Brazil Argentina Rest of South America

For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report:

Synthetic Biology Market Competitive Outlook

The synthetic biology market features a mix of biotechnology companies, research organizations, and technology providers focusing on innovation, scalability, and commercialization of engineered biological solutions. Market participants are investing in advanced platforms, expanding research capabilities, and forming strategic partnerships to accelerate product development and market penetration.

Companies are prioritizing advancements in gene editing, automation, and data-driven biological design to strengthen their competitive positioning and address the growing demand for synthetic biology applications across industries.

Major companies in the synthetic biology include:

    Genscript Thermo Fisher Scientific Inc. Amyris Inc. Integrated DNA Technologies Inc. (Danaher Corporation) Illumina, Inc.

Industry Related Reports by Mordor Intelligence

Microbiome Sequencing Services Market Size

Merieux Nutrisciences, Microbiome Insights, MR DNA, Baseclear and Clinical Microbiomics are the major companies operating in this market.

Read more about companies in the microbiome sequencing services market :

DNA Methylation Market Share

Cell-Free Protein Expression Market Analysis

Thermo Fisher Scientific Inc., Promega Corporation, Merck KGaA (Sigma-Aldrich), Takara Bio Inc. and New England Biolabs are the major companies operating in this market.

Read more about companies in the cell-free protein expression market :

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries, please contact:

[email protected]

Logo:

SOURCE Mordor Intelligence Private Limited

21% more press release views with Request a Demo

MENAFN09042026003732001241ID1110961084



PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search